Koligo Therapeutics (ASX:KOL) Interest Income: A$0.00 Mil (TTM As of . 20)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

What is Koligo Therapeutics Interest Income?

Koligo Therapeutics ASX:KOL Interest Income is A$0.00 Mil as of . 20.

Interest Income is the interest earned on cash temporarily held in savings accounts, certificates of deposits, or other investments. Koligo Therapeutics's interest income for the twelve months ended in . 20 was A$0.00 Mil. Its interest income for the trailing twelve months (TTM) ended in . 20 was A$0.00 Mil.

Koligo Therapeutics Interest Income Historical Data

* Premium members only.

The historical data trend for Koligo Therapeutics's Interest Income can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Koligo Therapeutics Interest Income Chart

Koligo Therapeutics Annual Data
Trend
Interest Income

Koligo Therapeutics Semi-Annual Data
Interest Income

Koligo Therapeutics Interest Income Calculation

Interest Income is the interest earned on cash temporarily held in savings accounts, certificates of deposits, or other investments.

For stock reported annually, GuruFocus uses latest annual data as the TTM data. Interest Income for the trailing twelve months (TTM) ended in . 20 was A$0.00 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Interest Income →
What does a Interest Income of A$0.00 Mil mean?
Koligo Therapeutics (ASX:KOL) has a Interest Income of A$0.00 Mil as of . 20. Interest Income is the amount a company receives on savings accounts and certificates of deposits. View historical data on Koligo Therapeutics and its competitors.
Is Koligo Therapeutics' Interest Income too high?
Koligo Therapeutics' current Interest Income is A$0.00 Mil.
How does Koligo Therapeutics' Interest Income compare to ?
Koligo Therapeutics' Interest Income of A$0.00 Mil can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Interest Income for a Biotechnology company?
A good Interest Income depends on the Biotechnology industry context. However, Interest Income should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Interest Income mean?
A high Interest Income can signal that a stock is expensive relative to its fundamentals. Interest Income is the amount a company receives on savings accounts and certificates of deposits. View historical data on Koligo Therapeutics and its competitors. Koligo Therapeutics's current Interest Income is A$0.00 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Koligo Therapeutics stock overvalued right now?
Koligo Therapeutics (ASX:KOL) has a current Interest Income of A$0.00 Mil. The current Interest Income is A$0.00 Mil. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Interest Income calculated?
Interest Income is calculated from a company's financial statements. For Koligo Therapeutics (ASX:KOL), the current Interest Income is A$0.00 Mil as of . 20. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Koligo Therapeutics Business Description

Comparable Companies